Task order establishing physical and chemical compatibility (PCC) study for acquired influenza a/astrakhan/3212/2020 (H5N8) antigen combined with MF59 adjuvant or AS03 adjuvant.
Ended Awarded Last action
- Contract number
- 75A50124F61017
- Awardee
-
Glaxosmithkline, LLC UEI FRHTPHMZMX47
- Awarding agency
-
Office of the Assistant Secretary for Preparedness and Response
Department of Health and Human Services
- Obligated
- $143,791
Award facts
- Contract value 100% obligated
- $143,791.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Durham, NC 27709, USA
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
Award details come from SAM.gov/FPDS.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Other Administrative Action | $0 | |
| Original award | $143,791 |
About this award
This federal contract award establishes a firm fixed price Delivery Order for a Physical and Chemical Compatibility (PCC) study on the Influenza A/Astrakhan/3212/2020 (H5N8) antigen combined with the MF59 adjuvant or the AS03 adjuvant. The Ceiling Value of the contract is $143,791.00, with an Ultimate Completion Date of July 15, 2025. The Prime Contractor is Glaxosmithkline, LLC, a pharmaceutical company that provides vaccines, antiviral medications, and other products to U.S. government agencies. The Funding Agency is the Office of the Assistant Secretary for Preparedness and Response, a civilian agency. This contract is not designated as a Set-Aside. Glaxosmithkline has received various federal contracts, grants, and subcontracts to support disease prevention efforts, immunization programs, drug stockpiling, and correctional healthcare services for agencies like the Departments of Defense, Veterans Affairs, and Health and Human Services.
Quick answers
Who was awarded contract 75A50124F61017?
75A50124F61017 was awarded to Glaxosmithkline, LLC by Office of the Assistant Secretary for Preparedness and Response (Department of Health and Human Services) on September 23, 2024.
How much is contract 75A50124F61017 worth?
The government has obligated $143,791 on 75A50124F61017.
Is contract 75A50124F61017 an order under another contract?
Yes. 75A50124F61017 is a delivery order under 75A50122D00002, an indefinite delivery contract.
Was contract 75A50124F61017 competed?
The extent of competition for 75A50124F61017 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award